BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 17, 2009
View Archived Issues
GSK claims calcium receptor antagonists for the treatment of bone and bone mineral disorders
Read More
sCD83 shows promising preclinical potential for the treatment of transplant rejection
Read More
Intramuscular laminin-111 delivery prevents degeneration in DMD mouse model
Read More
New guanylate cyclase activators under development at GSK for the treatment of hypertension
Read More
Schering-Plough discloses CDK2 and Chk1 inhibitors for cancer treatment
Read More
Galapagos initiates first-in-human phase I clinical trial of GLPG-0187 in bone metastasis
Read More
Cenix and AstraZeneca sign agreement in respiratory and inflammation-related indications
Read More
Advaxis reports survival data from phase I trial of live Listeria vaccine ADXS-11-001
Read More
Javelin reports results from phase I study of Dyloject in renal and hepatic impairment
Read More
Prospect Therapeutics reports results from in vitro studies of GCS-100 in cancer
Read More
ARYx Therapeutics provides update on tecarfarin EmbraceAC study
Read More
FDA extends review of BLA application for Arzerra
Read More
Almirall presents beta2-adrenoceptor agonists for the treatment of asthma
Read More
Taisho discovers histamine H3 receptor inhibitors for the treatment of Alzheimer's disease
Read More
ASCO snapshots: phase I/II data on novel treatments for metastatic breast cancer disclosed
Read More
Gastric pentadecapeptide BPC-157 shows beneficial cytoprotective effects in various rat models
Read More
Medicis launches Dysport in the U.S. for the treatment of glabellar lines
Read More
SIGA completes nonclinical toxicology studies in support of NDA for ST-246
Read More
Schering-Plough extends antibody alliance with MorphoSys until 2010
Read More
Pluristem receives European regulatory approval for placental-derived stem cell trial
Read More
FibroGen starts enrollment in phase II FG-3019 study in diabetic kidney disease
Read More
Bioalliance Pharma submits NDA to FDA for Loramyc
Read More
PhytoMedical presents update on its anticancer compound research and development
Read More
FDA committee recommends granting of marketing approval to Savient's Krystexxa for gout
Read More